Accordingly, a CDK1 inhibitor induces cell death in Burkitt lymphoma and multiple myeloma cell lines depending on MYC levels, and CDK1 inhibition in Eμ-Myc mice results in extended survival [224]. Here, CDK1 is linked to AL amyloidosis.